Latest filing published 01 Sept 2021 for TransMedics Group, Inc., €760.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John F. Sullivan: trading record in brief
John F. Sullivan is a declared insider of TransMedics Group, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 18 filings cover trades dated from 6 May 2019 to 30 August 2021.
The open-market record consists of 8 sales worth €931k, with no purchase. Besides market trades, the filings include 8 option exercises. In 2021 alone, the filings show no purchases and 6 sales.
On 1 September 2021 came the latest disclosure, an option exercise for €760 in TransMedics Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John F. Sullivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,200 shares@ US$0.28100.0% of flowCommon StockSEC:0000899243-21-034767:0
1 of 1 declaration